Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $22.10 | Total: $110.50 |
| 1 | 10 | $18.72 | Total: $187.20 |
| 1 | 25 | $15.86 | Total: $396.50 |
| 1 | 50 | $13.52 | Total: $676.00 |
| 1 | 100 | $11.70 | Total: $1,170.00 |
Overview
PKI-402 is a potent PI3K and mTOR inhibitor. PKI-402 inhibits PI3K?, mTOR, PI3K?, PI3K? and PI3K? with IC50s of 2, 3, 7, 14 and 16 nM, respectively.
Chemical Properties
| Molecular Formula | C29H34N10O3 |
| Molecular Weight | 570.65 |
| CAS Numbers | 1173204-81-3 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CCn1nnc2c(nc(nc12)-c1ccc(NC(=O)Nc2ccc(cc2)C(=O)N2CCN(C)CC2)cc1)N1CCOCC1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Mallon R et al. Antitumor efficacy profile of PKI-402, a dual phosphatidylinositol 3-kinasemammalian target of rapamycin inhibitor. Mol Cancer Ther. 2010 Apr;9[4] 976-84.